| 000 | 00629nas##2200193za#4500 |
|---|---|
| 001 | 9.514729 |
| 003 | CaOODSP |
| 005 | 20200331213156 |
| 007 | ta |
| 008 | 150406c1997||||xxc|| m #||||f| |0eng|d |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aH42-2/2E |
| 110 | 1 |aCanada.|bHealth Canada. |bTherapeutic Products Directorate. |
| 245 | 10|aTherapeutic Products Directorate guidelines |
| 260 | |aOttawa - Ontario : |bHealth Canada. |
| 563 | |aLoose-leaf |
| 775 | 08|tDirectives de la Direction des produits thérapeutiques |w(CaOODSP)9.513089 |
| 776 | 0#|tTherapeutic Products Directorate guidelines |w(CaOODSP)9.506920 |